Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
Comment from the depositor
Terms and conditions
1) A permission of the approver is required. 2) The users should sign an MTA with Osaka University. 3) In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Matrix Biol 2006;25:85-88) designated by the DEPOSITOR is required.
Remarks
approver's address
×
English
Address
Institute for Protein Research, Osaka University Laboratory of Extracellular Matrix Biochemistry 3-2 Yamadaoka, Suita, Osaka 565-0871 Japan
Dr.SEKIGUCHI Kiyotoshi
Fax. +81-6-6879-8619
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
3562
Hayashi Y, Weber CN, Emoto T, Fujiwara H, Sanzen N, Futaki S, Sekiguchi K.
A novel large-scale production system for modified basement membrane matrices using gene-swapped parietal endoderm cells.Matrix Biol
2006
25(2):85-8
PubMed ID: 16314080
DOI: 10.1016/j.matbio.2005.10.004
2493
Strickland S, Mahdavi V.
The induction of differentiation in teratocarcinoma stem cells by retinoic acid.Cell
1978
15(2):393-403
PubMed ID: 214238
DOI: 10.1016/0092-8674(78)90008-9